to enjoy learning and progressing in cardiometabolic practice



Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy





Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrumVICTORIA and VICTOR Clinical Trials

Reduction of Antihypertensive Treatment in Nursing Home Residents

High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults

Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction (TARGET-FIRST)

Apixaban for Extended Treatment of Provoked Venous Thromboembolism (HI-PRO)

Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF RCT

SGLT2 inhibitors in CKD: are they really effective in all patients?

DOACs for Rheumatic Heart Disease-Associated AF Post-Bioprosthetic MVR

22nd ACC 2025 Congress Coverage: FLAVOUR II Trial

Case Discussion 124: Anticoagulation in Patients with Mitral Stenosis

23rd ACC 2025 Congress Coverage: FAME 3 Trial

19th ACC 2025 Congress Coverage: HPV Infection and Cardiovascular Disease

18th ACC 2025 Congress Coverage: SOUL Trial

11th ACC 2025: HOST-BR Trial

12th ACC 2025: RIVAWAR Trial

6th ACC 2025: FRESH-UP Study

14th ACC 2025: SBP < 130 mmHg Linked to Reduced CV Mortality in Adults +80 Y

15th ACC 2025: DapaTAVI Trial

9th ACC 2025: ALIGN-AR Trial

10th ACC 2025: FAIR-HF2 Trial

16th ACC 2025: MI and Cardiovascular Risks Associated with Cannabis Use

8th ACC 2025: BHF PROTECT-TAVI Trial

2nd ACC 2025: ADVANCE-HTN Trial

1st ACC 2025: SMART-CHOICE 3 Trial

Antithrombotic Therapy in CCS

Antithrombotic Therapy in ACS

Antithrombotic Therapy in VTE

Antithrombotic Therapy in AF

POCUS Basic Echocardiography